Status:
UNKNOWN
Study Protocol Evaluating Transient Tachypnoea of the Newborn in Term and Near Term Neonates
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Transient Tachypnoea of the Newborn
Eligibility:
All Genders
Up to 6 years
Phase:
NA
Brief Summary
Transient tachypnoea of the newborn (TTN) is a common cause of hospitalisation in the neonatal period, complicating 1 to 1,5 per cent life birth. Predisposing factors are prematurity, birth after C se...
Eligibility Criteria
Inclusion
- Neonate \> or = 34 weeks GA admitted in the first 6 hours of life with the suspected diagnosis of TTN (respiratory rate \> 60/mn, SpO2 \< 90% in room air, ilvermann score \> 0
- Parental consent obtained
Exclusion
- GA\> 42 weeks
- meconial amniotic fluid
- early onset neonatal sepsis (septic shock)
- congenital malformations
- enteral feeding started before admission
- no parental consent
Key Trial Info
Start Date :
November 1 2004
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00213941
Start Date
November 1 2004
Last Update
October 3 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Pédiatrie 2, Hôpital de Hautepierre
Strasbourg, France, 67098